We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
LSE:0A43
​
​
logo

Inovio Pharmaceuticals (0A43)

LSE • 0A43 • US45773H4092

1.36Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 27, 2026, ORTEX estimated 5.6% of free float sold short, 154.7 days to cover, cost to borrow 2.69%. Sign up for live short interest data.

Market Cap

266m USD | # 2901 in GB

Volume

181.47k shares | 13.15m USD

Shares Outstanding

168.93m

Free Float Shares

99.77% | 168.54m

Nasdaq:INO|
DB:GBM

News

0A43 key data

Inovio Pharmaceuticals (LSE: 0A43) has a market capitalization of $265.87M. Last close $1.36 (as of 2026-11-12); 52-week range $0.57 to $2.72. ORTEX data as of 2026-10-27: short interest was 5.62% of free float, 154.7 days to cover and the average cost to borrow was 2.69%. Sign up for live short interest data.

  • 0A43 news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.